AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2017
May 11, 2017
30826_dirs_2017-05-11_7fcf9220-cbf4-4b74-8c48-de526b2cab92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2017-05-10
Reporting Person: Hunt Anthony (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-10 | Common Stock | F | 2275 | $37.9749 | Disposed | 92583 | Direct |
Footnotes
F1: Payment of tax liability made via forfeiture of 2,275 shares of Common Stock valued at a weighted average price of $37.9749 per share on May 10, 2017.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23